Literature DB >> 2413136

Selective defects in cytomegalovirus- and mitogen-induced lymphocyte proliferation and interferon release in patients with acquired immunodeficiency syndrome.

J S Epstein, W R Frederick, A H Rook, L Jackson, J F Manischewitz, R E Mayner, H Masur, J C Enterline, J Y Djeu, G V Quinnan.   

Abstract

To examine the defect in cellular immunity in patients with acquired immunodeficiency syndrome (AIDS), we studied in vitro lymphocyte proliferation and interferon (IFN) release in response to cytomegalovirus (CMV) antigen and Concanavalin A mitogen in 40 homosexual men with AIDS, 10 homosexual men with chronic lymphadenopathy syndrome, 7 healthy homosexual men, and 18 healthy heterosexual subjects of either sex. CMV serology by an enzyme-linked immunosorbent assay and viral cultures for CMV were performed. Lymphocytes of patients with AIDS showed impaired CMV-specific release of IFN but normal mitogen-induced IFN release. The defect was not attributable to CMV infection per se. Cell proliferation in response to both CMV antigen and mitogen was impaired in patients with AIDS who had opportunistic infections. The defect could not be attributed to CMV viremia. We concluded that impaired release of IFN in response to a viral antigen is characteristic of lymphocytes in patients with AIDS and that this defect is distinct from a defect in mitogenic responsiveness, which coexists predominantly in patients with opportunistic infections.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2413136     DOI: 10.1093/infdis/152.4.727

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  14 in total

1.  Immune response to cytomegalovirus in patients with acquired-immunodeficiency syndrome related complex (ARC) and AIDS.

Authors:  M C Sirianni; A Volpi; S Soddu; R Mancino; F Aiuti; G Rocchi
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

2.  Pathogenic and protective correlates of T cell proliferation in AIDS. HNRC Group. HIV Neurobehavioral Research Center.

Authors:  R D Schrier; C A Wiley; C Spina; J A McCutchan; I Grant
Journal:  J Clin Invest       Date:  1996-08-01       Impact factor: 14.808

3.  Stress reduction training changed number of sexual partners but not immune function in men with HIV.

Authors:  T J Coates; L McKusick; R Kuno; D P Stites
Journal:  Am J Public Health       Date:  1989-07       Impact factor: 9.308

4.  Characteristics of the specific cell-mediated immune response in human immunodeficiency virus infection.

Authors:  B Wahren; L Morfeldt-Månsson; G Biberfeld; L Moberg; A Sönnerborg; P Ljungman; A Werner; R Kurth; R Gallo; D Bolognesi
Journal:  J Virol       Date:  1987-06       Impact factor: 5.103

5.  Replication of cytomegalovirus in human thymic epithelial cells.

Authors:  K Numazaki; L DeStephano; I Wong; H Goldman; B Spira; M A Wainberg
Journal:  Med Microbiol Immunol       Date:  1989       Impact factor: 3.402

6.  B- and T-lymphocyte responses to an immunodominant epitope of human immunodeficiency virus.

Authors:  R D Schrier; J W Gnann; A J Langlois; K Shriver; J A Nelson; M B Oldstone
Journal:  J Virol       Date:  1988-08       Impact factor: 5.103

7.  Persistent infection of rabbits with bovine leukemia virus associated with development of immune dysfunction.

Authors:  C R Wyatt; D Wingett; J S White; C D Buck; D Knowles; R Reeves; N S Magnuson
Journal:  J Virol       Date:  1989-11       Impact factor: 5.103

8.  Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group.

Authors:  R D Schrier; W R Freeman; C A Wiley; J A McCutchan
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

9.  Functional impairment of simian immunodeficiency virus-specific CD8+ T cells during the chronic phase of infection.

Authors:  T U Vogel; T M Allen; J D Altman; D I Watkins
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

10.  An early defect in primary and secondary T cell responses in asymptomatic cats during acute feline immunodeficiency virus (FIV) infection.

Authors:  S A Bishop; N A Williams; T J Gruffydd-Jones; D A Harbour; C R Stokes
Journal:  Clin Exp Immunol       Date:  1992-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.